In the light of the new scientific and technical knowledge, the Commission considered that there are indications that the approved uses of clothianidin, thiamethoxam and imidacloprid no longer satisfy the approval criteria provided for in Article 4 of Regulation (EC) No 1107/2009 with respect to their impact on bees and that the high risk for bees could not be excluded except by imposing further restrictions. In particular, pending the evaluation of the Authority on foliar uses it considered that the risk for bees from foliar applications is similar to the risk identified by the Authority for seed treatment applications and soil treatment, due to the systemic translocation of the active substances clothianidin, thiamethoxam and imidacloprid through the plant.
Recital 7, Commission Implementing Regulation (EU) No 485/2013 of 24 May 2013 amending Implementing…
In forcesince 24 May 2013cited 1×
Judgment of the General Court (First Chamber, Extended Composition) of 17 May 2018. Bayer CropScience AG and Others v European Commission.Decision
The applicants submit that even though, at the time when the contested measure was adopted, EFSA had not assessed foliar uses of the substances covered, the measure nonetheless restricts such use. They claim that the simplistic assertion …
17 May 2018 · 62013TJ0429